Document

Singapore – November 13, 2024 – Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S,” “our,” or the “Company”), today announced the financial results of its fourth fiscal quarter ended September 28, 2024. The Company reported fourth quarter net revenue of $181.3 million, net income of $12.1 million, representing EPS of $0.22 per fully diluted shares, and non-GAAP net income of $18.5 million, representing non-GAAP EPS of $0.34 per fully diluted share.


	Fiscal Q4 2024	Change vs. Fiscal Q4 2023	Change vs. Fiscal Q3 2024
Net Revenue	$181.3 million	down 10.4%	down 0.2%

Gross Margin	48.3%	up 90 bps	up 170 bps
Income from Operations	$2.7 million	down 86.2%	down 67.5%
Operating Margin	1.5%	down 810 bps	down 310 bps
Net Income	$12.1 million	down 48.1%	down 1.2%
Net Margin	6.7%	down 480 bps	down 10 bps
EPS – Diluted	$0.22	down 46.3%	up 0%

Fusen Chen, Kulicke & Soffa’s President and Chief Executive Officer, stated, “We continue to drive market adoption of our advanced packaging and assembly solutions including vertical wire, high-power interconnect (HPI), advanced dispense and fluxless thermo-compression (FTC). Demand for these solutions is anticipated to accelerate along with coordinated General Semiconductor and Automotive market recovery through fiscal year 2025."

The transition to emerging chiplet and heterogeneous applications — which are enabling new levels of performance and transistor density — position Kulicke & Soffa for additional share gains within leading-edge logic. Beyond this emerging FTC solution which is supporting leading-edge assembly transitions; high-volume memory, automotive and LED applications are also requiring new assembly solutions which can deliver package-level transistor density improvements. These growing market needs are being directly supported through Kulicke & Soffa's portfolio of vertical wire, advanced dispense and advanced display solutions.

The Company currently expects net revenue in the first fiscal quarter of 2025, ending December 28, 2024, to be approximately $165.0 million, +/- $10 million, GAAP diluted EPS to be approximately $1.45 +/- 10%, and non-GAAP diluted EPS to be approximately $0.28, +/- 10%. This outlook includes favorable claim/proceeds relating to cessation of business due to the cancellation of Project W - which was disclosed on March 11, 2024.

A webcast to discuss these results will be held tomorrow, November 14, 2024, beginning at 8:00am EST. The live webcast link, supplemental earnings presentation, and archived webcast will be available at investor.kns.com. To access the audio-only portion of the live webcast, parties may call +1-877-407-8037 or internationally +1-201-689-8037.

In addition to U.S. GAAP results, this press release also contains the following non-GAAP financial results: income from operations, operating margin, net income, net margin, net income per fully diluted share and adjusted free cash flow. The Company's non-GAAP results exclude amortization related to intangible assets acquired through business combinations, costs associated with restructuring and severance, equity-based compensation, acquisition and integration cost, impairment relating to assets acquired through business combinations, long-lived asset impairment relating to business cessation or disposal, impairment relating to equity investments, income tax expense arising from discrete tax items triggered by acquisition, disposal of business (both via a sale or an abandonment), restructuring and significant changes in tax laws, gain/loss on disposal of business, as well as tax benefits or expenses associated with the foregoing non-GAAP items. The non-GAAP adjustments may or may not be infrequent or nonrecurring in nature, but are a result of periodic or non-core operating activities. These non-GAAP measures are consistent with the way management analyzes and assesses the Company’s operating results. The Company believes these non-GAAP measures enhance investors’ understanding of the Company’s underlying operational performance, as well as their ability to compare the Company’s period-to-period financial results and the Company’s overall performance to that of its competitors.

Management uses both U.S. GAAP metrics as well as non-GAAP metrics to evaluate the Company’s operating and financial results. Non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in the Company’s industry, as other companies in the industry may calculate non-GAAP financial results differently. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on the Company’s reported financial results. The presentation of non-GAAP items is meant to supplement, but not substitute for, GAAP financial measures or information. The Company believes the presentation of non-GAAP results in combination with GAAP results provides better transparency to the investment community when analyzing business trends, providing meaningful comparisons with prior period performance and enhancing investors’ ability to view the Company's results from management's perspective. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP measure discussed in this press release is contained in the financial tables at the end of this press release.

Founded in 1951, Kulicke & Soffa specializes in developing cutting-edge semiconductor and electronics assembly solutions enabling a smart and more sustainable future. Our ever-growing range of products and services supports growth and facilitates technology transitions across large-scale markets, such as advanced display, automotive, communications, compute, consumer, data storage, energy storage and industrial.

In addition to historical statements, this press release contains statements relating to future events and our future results. These statements are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our judgments and future expectations concerning our business, including the importance and competitiveness of our thermo-compression products and other emerging technology transitions, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, the persistent macroeconomic headwinds on our business, actual or potential inflationary pressures, disruptions, breaches or failures in our information technology systems and network infrastructures, interest rate and risk premium adjustments, falling customer sentiment, or economic recession caused directly or indirectly by geopolitical tensions, our ability to develop, manufacture and gain market acceptance of new products, our ability to operate our business in accordance with our business plan and the other factors listed or discussed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed on November 16, 2023, and our other filings with the Securities and Exchange Commission. Kulicke and Soffa Industries, Inc. is under no obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


	Three months ended				Twelve months ended
	September 28, 2024		September 30, 2023		September 28, 2024		September 30, 2023
Net revenue	$	181,319	$	202,320	$	706,232	$	742,491
Cost of sales	93,662		106,481		437,478		383,836
Gross profit	87,657		95,839		268,754		358,655

Operating expenses:
Selling, general and administrative	42,645		37,380		155,142		145,493
Research and development	38,763		37,616		151,214		144,701
Impairment charges	—		—		44,472		21,535
Acquisition-related cost	—		13		—		511
Amortization of intangible assets	1,266		1,356		5,188		6,099
Restructuring	2,294		—		5,234		879
Total operating expenses	84,968		76,365		361,250		319,218





Income/(loss) from operations	2,689		19,474		(92,496)		39,437

Other income / (expense):
Interest income	7,423		9,500		34,230		32,906
Interest expense	(29)		(26)		(89)		(142)

Income/(loss) before income taxes	10,083		28,948		(58,355)		72,201
Income tax (benefit) / expense	(2,034)		5,591		10,651		15,053

Net income / (loss)	$	12,117	$	23,357	$	(69,006)	$	57,148

Net income / (loss) per share:
Basic	$	0.22	$	0.41	$	(1.24)	$	1.01
Diluted	$	0.22	$	0.41	$	(1.24)	$	0.99

Cash dividends declared per share	$	0.20	$	0.19	$	0.80	$	0.76

Weighted average shares outstanding:
Basic	54,368		56,442		55,613		56,682
Diluted	54,871		57,408		55,613		57,548


	Three months ended				Twelve months ended
Supplemental financial data:	September 28, 2024		September 30, 2023		September 28, 2024		September 30, 2023
Depreciation and amortization	$	4,839	$	8,111	$	24,735	$	28,857
Capital expenditures	3,091		4,217		13,736		47,702
Equity-based compensation expense:
Cost of sales	240		289		1,277		1,192
Selling, general and administrative	4,441		3,841		18,524		16,239
Research and development	1,758		1,311		7,090		5,313
Total equity-based compensation expense	$	6,439	$	5,441	$	26,891	$	22,744


	As of
	September 28, 2024		September 30, 2023
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	227,147	$	529,402

Short-term investments	350,000		230,000
Accounts and notes receivable, net of allowance for doubtful accounts of $49 and $49 respectively	193,909		158,601
Inventories, net	177,736		217,304
Prepaid expenses and other current assets	46,161		53,751

TOTAL CURRENT ASSETS	994,953		1,189,058

Property, plant and equipment, net	64,823		110,051
Operating right-of-use assets	35,923		47,148
Goodwill	89,748		88,673
Intangible assets, net	25,239		29,357
Deferred tax assets	17,900		31,551
Equity investments	3,143		716
Other assets	8,433		3,223
TOTAL ASSETS	$	1,240,162	$	1,499,777

LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES

Accounts payable	58,847		49,302
Operating lease liabilities	7,718		6,574
Accrued expenses and other current liabilities	90,802		103,005
Income taxes payable	26,427		22,670
TOTAL CURRENT LIABILITIES	183,794		181,551


Deferred tax liabilities	34,594		37,264
Income taxes payable	31,352		52,793
Operating lease liabilities	33,245		41,839
Other liabilities	13,168		11,769
TOTAL LIABILITIES	$	296,153	$	325,216

SHAREHOLDERS' EQUITY
Common stock, no par value	596,703		577,727
Treasury stock, at cost	(881,830)		(737,214)
Retained earnings	1,242,558		1,355,810
Accumulated other comprehensive loss	(13,422)		(21,762)
TOTAL SHAREHOLDERS' EQUITY	$	944,009	$	1,174,561

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	1,240,162	$	1,499,777


	Three months ended				Twelve months ended
	September 28, 2024		September 30, 2023		September 28, 2024		September 30, 2023
Net cash provided by operating activities	$	31,619	$	77,492	$	31,037	$	173,404
Net cash (used in) / provided by investing activities, continuing operations	(117,983)		70,386		(138,501)		(91,338)
Net cash used in financing activities, continuing operations	(54,371)		(19,518)		(196,100)		(111,876)
Effect of exchange rate changes on cash and cash equivalents	965		(764)		1,309		3,675
Changes in cash and cash equivalents	(139,770)		127,596		(302,255)		(26,135)
Cash and cash equivalents, beginning of period	366,917		401,806		529,402		555,537
Cash and cash equivalents, end of period	$	227,147	$	529,402	$	227,147	$	529,402

Short-term investments	350,000		230,000		350,000		230,000
Total cash, cash equivalents, and short-term investments	$	577,147	$	759,402	$	577,147	$	759,402


	Three months ended
	September 28, 2024			September 30, 2023			June 29, 2024
Net revenue	$	181,319		$	202,320		$	181,650
U.S. GAAP income from operations	2,689			19,474			8,277
U.S. GAAP operating margin	1.5		%	9.6		%	4.6		%

Pre-tax non-GAAP items:
Amortization related to intangible assets	$	1,266		$	1,356		1,250
Acquisition-related costs	—			13			—
Equity-based compensation	6,439			5,441			6,363
Restructuring	2,294			—			—

Non-GAAP income from operations	$	12,688		$	26,284		$	15,890
Non-GAAP operating margin	7.0		%	13.0		%	8.7		%


	Twelve months ended			Three months ended
	September 28, 2024			September 28, 2024			September 30, 2023			June 29, 2024
Net revenue	$	706,232		$	181,319		$	202,320		$	181,650
U.S. GAAP net income	(69,006)			12,117			23,357			12,264
U.S. GAAP net margin	(9.8)		%	6.7		%	11.5		%	6.8		%

Non-GAAP adjustments:
Amortization related to intangible assets	$	5,188		$	1,266		$	1,356		1,250
Restructuring	5,234			2,294			—			—
Acquisition-related costs	—			—			13			—
Equity-based compensation	26,891			6,439			5,441			6,363
Impairment charges	44,472			—			—			—
Income tax benefit - US one-time transition tax	(6,461)			(6,461)			—			—
Net income tax (benefit)/expense on non-GAAP items	(4,752)			2,866			(758)			(568)
Total non-GAAP adjustments	70,572			6,404			6,052			7,045
Non-GAAP net income	1,566			18,521			29,409			19,309
Non-GAAP net margin	0.2		%	10.2		%	14.5		%	10.6		%

U.S. GAAP net income per share:
Basic	(1.24)			0.22			0.41			0.22
Diluted(a)	(1.24)			0.22			0.41			0.22

Non-GAAP adjustments per share:(b)
Basic	1.27			0.12			0.11			0.13
Diluted	1.27			0.12			0.10			0.13

Non-GAAP net income per share:
Basic	$	0.03		$	0.34		$	0.52		$	0.35
Diluted(c)	$	0.03		$	0.34		$	0.51		$	0.35

Weighted average shares outstanding:
Basic	55,613			54,368			56,442			55,280
Diluted	55,613			54,871			57,408			55,724

(b)Non-GAAP adjustments per share includes amortization related to intangible assets acquired through business combinations, costs associated with restructuring and severance, acquisition and integration cost, equity-based compensation expenses, impairment relating to business cessation or disposal, income tax benefit from the U.S. Tax Court opinion in Varian Medical Systems, Inc. v. Commissioner related to the U.S. one-time transition tax and income tax effects associated with the foregoing non-GAAP items.


	Twelve months ended		Three months ended
	September 28, 2024		September 28, 2024		September 30, 2023		June 29, 2024
U.S. GAAP net cash provided by operating activities	$	31,037	$	31,619	$	77,492	$	26,897
Expenditures for property, plant and equipment	(16,148)		(2,468)		(9,281)		(2,683)
Proceeds from sales of property, plant and equipment	27		27		273		—

Non-GAAP adjusted free cash flow	14,916		29,178		68,484		24,214

First quarter of fiscal 2025 ending December 28, 2024

GAAP Outlook

Adjustments

Non-GAAP Outlook

Net revenue

$165 million

+/- $10 million

—

$165 million

+/- $10 million

Operating expenses

$4.0 million

+/- 2%

$(66.5) million B,C, D,E

$70.5 million

+/- 2%

Diluted EPS(1)

$1.45

+/- 10%

$(1.17) A, B, C, D ,E, F

$0.28

+/- 10%

Non-GAAP Adjustments

A. Equity-based compensation - Cost of sales

0.5

B. Equity-based compensation - Selling, general and administrative and Research and development

6.3

C. Amortization related to intangible assets

1.4

D. Restructuring expenses

0.8

E. Claim/proceeds relating to cessation of business

(75.0)

F. Net income tax effect of the above items

2.4

The tables above reconcile our GAAP to non-GAAP guidance based on the current outlook. The guidance does not incorporate the impact of any potential business combinations, divestitures, restructuring activities, strategic investments and other significant transactions. The timing and impact of such items are dependent on future events that may be uncertain or outside of our control.


	Fiscal Q4 2024	Change vs. Fiscal Q4 2023	Change vs. Fiscal Q3 2024
Income from Operations	$12.7 million	down 51.7%	down 20.2%
Operating Margin	7.0%	down 600 bps	down 170 bps
Net Income	$18.5 million	down 37%	down 4.1%
Net Margin	10.2%	down 430 bps	down 40 bps
EPS - Diluted	$0.34	down 33.3%	down 2.9%


Kulicke and Soffa Industries, Inc.
Joseph Elgindy
Finance
P: +1-215-784-7518


			Kulicke & Soffa Pte. Ltd. 23A Serangoon North Ave 5 Singapore 554369 +65 6880-9600 main Co. Regn. No. 199902120H
			Kulicke and Soffa Industries, Inc. 1005 Virginia Drive Fort Washington, PA 19034 USA +1-215-784-6000 main www.kns.com